Creese, Byron http://orcid.org/0000-0001-6490-6037
Vassos, Evangelos http://orcid.org/0000-0001-6363-0438
Bergh, Sverre
Athanasiu, Lavinia
Johar, Iskandar
Rongve, Arvid
Medbøen, Ingrid Tøndel
Vasconcelos Da Silva, Miguel
Aakhus, Eivind
Andersen, Fred
Bettella, Francesco http://orcid.org/0000-0001-7968-8642
Braekhus, Anne
Djurovic, Srdjan http://orcid.org/0000-0002-8140-8061
Paroni, Giulia
Proitsi, Petroula http://orcid.org/0000-0002-2553-6974
Saltvedt, Ingvild
Seripa, Davide
Stordal, Eystein
Fladby, Tormod
Aarsland, Dag
Andreassen, Ole A.
Ballard, Clive
Selbaek, Geir http://orcid.org/0000-0001-6511-8219
,
Article History
Received: 16 August 2019
Revised: 6 September 2019
Accepted: 23 September 2019
First Online: 22 October 2019
Conflict of interest
: C.B. has received contract grant funding from Lundbeck, Takeda, and Axovant pharmaceutical companies and honoraria from Lundbeck, Lilly, Otusaka, and Orion pharmaceutical companies. D.A. has received research support and/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals, and GE Health, and serves as a paid consultant for H. Lundbeck and Axovant. The remaining authors declare that they have no conflict of interest.